Home
Market Capitalization of Auro Laboratories Ltd

Auro Laboratories Ltd
NSE: AUROLABS
Market Cap
Key Highlights
- The Market Cap of Auro Laboratories Ltd is ₹ 153.48 crore as of 07 Apr 25 .
- The Latest Trading Price of Auro Laboratories Ltd is ₹ 257 as of 08 Apr 12:58 .

Auro Laboratories Ltd
NSE: AUROLABS
Share Price
Market Price of Auro Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
07 Apr 2025 | 246.35 |
04 Apr 2025 | 251.2 |
03 Apr 2025 | 256.85 |
02 Apr 2025 | 245.1 |
01 Apr 2025 | 241.9 |
28 Mar 2025 | 230.55 |
27 Mar 2025 | 231.75 |
26 Mar 2025 | 238.9 |
25 Mar 2025 | 239.1 |
24 Mar 2025 | 240.75 |
SWOT Analysis Of Auro Laboratories Ltd
BlinkX Score for Auro Laboratories Ltd
Asset Value vs Market Value of Auro Laboratories Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Auro Laboratories Ltd
Historical P/E Ratio of Auro Laboratories Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Auro Laboratories Ltd
Historical Revenue of Auro Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Auro Laboratories Ltd
Historical EBITDA of Auro Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Auro Laboratories Ltd
Historical Net Profit of Auro Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Auro Laboratories Ltd
Dividend Payout Over Time
About Auro Laboratories Ltd
- Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API).
- Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes.
- The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
- The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards.
- Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments.
Auro Laboratories Ltd News Hub
Auro Laboratories standalone net profit rises 5.63% in the June 2024 quarter
Net profit of Auro Laboratories rose 5.63% to Rs 0.75 crore in the quarter ended June 2024 as agains
Read more
10 Aug 24
Auro Laboratories to announce Quarterly Result
Auro Laboratories will hold a meeting of the Board of Directors of the Company on 9 August 2024 Powe
Read more
01 Aug 24
Auro Laboratories to hold board meeting
Auro Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2024 P
Read more
06 Nov 24
Auro Laboratories standalone net profit declines 81.73% in the September 2024 quarter
Net profit of Auro Laboratories declined 81.73% to Rs 0.36 crore in the quarter ended September 2024
Read more
12 Nov 24